The gut microbiota and the liver. Pathophysiological and clinical implications

Journal of Hepatology

Volumn 58, Issue 5, 2013, Pages 1020-1027

  Quigley, Eamonn M M ^a,b   Stanton, Catherine ^a,c   Murphy, Eileen F ^a,d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d ALIMENTARY HEALTH LTD   (Ireland)

Author keywords

Antibiotics; Bacteraemia; Bacteria; Cirrhosis; Hepatic encephalopathy; Liver; Microbiota; Prebiotics; Probiotics

Indexed keywords

ACETALDEHYDE; ANTIBIOTIC AGENT; ENDOTOXIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN LIPASE ACTIVATOR; METRONIDAZOLE; PREBIOTIC AGENT; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER INJURY; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ANTIBIOTIC THERAPY; ARCHAEON; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIUM; BODY MASS; CYTOKINE PRODUCTION; DIET; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HUMAN; INTESTINAL FAILURE; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; INTESTINE FLORA; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; MEDIATOR; NONALCOHOLIC FATTY LIVER; NUTRIENT; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTOZOON; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE; SYSTEMATIC REVIEW; TOTAL PARENTERAL NUTRITION; VIRUS;

GASTROINTESTINAL TRACT; HEMODYNAMICS; HOMEOSTASIS; HUMANS; LIVER; LIVER DISEASES; MICROBIOTA;

EID: 84876283537     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.023     Document Type: Review

References (111)

1. G.B. Phillips, R. Schwartz, G.J. Gabuzda Jr., and C.S. Davidson The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances N Engl J Med 247 1952 239 246
2. G.A. Martini, E.A. Phear, B. Ruebner, and S. Sherlock The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity Clin Sci 16 1957 35 51
3. E.A. Phear, B. Ruebner, S. Sherlock, and W.H. Summerskill Methionine toxicity in liver disease and its prevention by chlortetracycline Clin Sci 15 1956 93 117
4. G. Szabo, S. Bala, J. Petrasek, and A. Gattu Gut-liver axis and sensing microbes Dig Dis. 28 2010 737 744
5. A. Abu-Shanab, and E.M. Quigley The role of the gut microbiota in nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 691 701
6. E.M.M. Quigley, M.N. Marsh, J.L. Shaffer, and R.S. Markin Hepatobiliary complications of total parenteral nutrition Gastroenterology 104 1993 286 301
7. B. Terjung, and U. Spengler Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"? Clin Rev Allergy Immunol 36 2009 40 51
8. B. Terjung, J. Söhne, B. Lechtenberg, J. Gottwein, M. Muennich, and V. Herzog P-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ Gut 59 2010 808 816
9. E.M.M. Quigley Gastrointestinal dysfunction in liver disease-gut-liver interactions revisited Dig Dis Sci 41 1996 557 561
10. U. Thalheimer, C.K. Triantos, D.N. Samonakis, D. Patch, and A.K. Burroughs Infection, coagulation and variceal bleeding in cirrhosis Gut 54 2005 556 563
11. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
12. J. Qin, R. Li, J. Raes, M. Arumugam, K.S. Burgdorf, and C. Manichanh A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 U59 U70
13. J.C. Clemente, L.K. Ursell, L.W. Parfrey, and R. Knight The impact of the gut microbiota on human health: an integrative view Cell 148 2012 1258 1270
14. F. Backhed Programming of host metabolism by the gut microbiota Ann Nutr Metab 58 2011 44 52
15. T.M. Marques, R. Wall, R.P. Ross, G.F. Fitzgerald, C.A. Ryan, and C. Stanton Programming infant gut microbiota: influence of dietary and environmental factors Curr Opin Biotechnol 21 2010 149 156
16. A.M. Kosloske Pathogenesis and prevention of necrotizing enterocolitis- a hypothesis based on personal observation and a review of the literature Pediatrics 74 1984 1086 1092
17. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology-human gut microbes associated with obesity Nature 444 2006 1022 1023
18. A. Kassinen, L. Krogius-Kurikka, H. Makivuokko, T. Rinttila, L. Paulin, and J. Corander The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects Gastroenterology 133 2007 24 33
19. D.A. Peterson, D.N. Frank, N.R. Pace, and J.I. Gordon Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases Cell Host Microbe 3 2008 417 427
20. H.J. Flint, P.W. O'Toole, and A.W. Walker Special issue: the human intestinal microbiota Microbiology 156 2010 3203 3204
21. I.B. Jeffery, E.M. Quigley, L. Ohman, M. Simrén, and P.W. O'Toole The microbiota link to Irritable Bowel Syndrome: an emerging story Gut Microbes 2012 3 [Epub ahead of print]
22. F. Shanahan The gut microbiota in 2011: translating the microbiota to medicine Nat Rev Gastroenterol Hepatol 9 2011 72 74
23. B. Hoefert Über die bakterienbefunde im duodenalsaft von gesunden und kranken Zschr Klin Med 92 1921 221 235
24. V.B. Nieuwenhuijs, A. Verheem, H. van Duijvenbode-Beumer, M.R. Visser, J. Verhoef, and H.G. Gooszen The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats Ann Surg 228 1998 188 193
25. E. Husebye Gastrointestinal motility disorders and bacterial overgrowth J Intern Med 237 1995 419 427
26. C.Y. Yang, C.S. Chang, and G.H. Chen Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests Scand J Gastroenterol 33 1998 867 871
27. A. Abu Shanab, P. Scully, O. Crosbie, M. Buckley, L. O'Mahony, and F. Shanahan Small intestinal bacterial overgrowth in non-alcoholic steato-hepatitis; association with toll-like receptor 4 expression and plasma levels of interleukin 8 Dig Dis Sci 56 2011 1524 1534
28. A. Gupta, R.K. Dhiman, S. Kumari, S. Rana, R. Agarwal, and Y. Duseja Chawla Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy J Hepatol 53 2010 849 855
29. E.M.M. Quigley The liver and gastrointestinal disease E.R. Schiff, M.F. Sorrell, W.C. Maddrey, Schiff's diseases of the liver 9th ed. 2002 Lippincott Raven Philadelphia
30. Z. Teltschik, R. Wiest, J. Beisner, S. Nuding, C. Hofmann, and J. Schoelmerich Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense Hepatology 55 2012 1154 1163
31. V. Purohit, J.C. Bode, C. Bode, D.A. Brenner, M.A. Choudhry, and F. Hamilton Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium Alcohol 42 2008 349 361
32. M.H. Fraher, P.W. O'Toole, and E.M.M. Quigley Techniques used to characterise the intestinal microbiota: a guide for the clinician Nat Rev Gastroenterol 9 2012 312 322
33. C. Palmer, E.M. Bik, D.B. DiGiulio, D.A. Relman, and P.O. Brown Development of the human infant intestinal microbiota PLoS Biol 5 2007 1556 1573
34. M.J. Claesson, S. Cusack, O. O'Sullivan, R. Greene-Diniz, H. de Weerd, and E. Flannery Composition, variability, and temporal stability of the intestinal microbiota of the elderly PNAS 108 2011 4586 4591
35. M.J. Claesson, I.B. Jeffery, S. Conde, S.E. Power, E.M. O'Connor, and S. Cusack Gut microbiota composition correlates with diet and health in the elderly Nature 488 2012 178 184
36. F. Fouhy, R.P. Ross, G.F. Fitzgerald, C. Stanton, and P.D. Cotter Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps Gut Microbes 3 2012 203 220
37. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, and M. Sargent Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
38. J.E. Koenig, A. Spor, N. Scalfone, A.D. Fricker, J. Stombaugh, and R. Knight Succession of microbial consortia in the developing infant gut microbiome PNAS 108 2011 4578 4585
39. M. Arumugam, J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, and D.R. Mende Enterotypes of the human gut microbiome Nature 473 2011 174 180
40. D. Mariat, O. Firmesse, F. Levenez, V.D. Guimaraes, H. Sokol, and J. Dore The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age BMC Microbiol 9 2009 123
41. P.W. O'Toole, and M.J. Claesson Gut microbiota: changes throughout the lifespan from infancy to elderly Int Dairy J 20 2010 281 291
42. Y. Chen, F. Yang, H. Lu, B. Wang, Y. Chen, and D. Lei Characterization of fecal microbial communities in patients with liver cirrhosis Hepatology 54 2011 562 572
43. J.S. Bajaj, J.M. Ridlon, P.B. Hylemon, L.R. Thacker, D.M. Heuman, and S. Smith Linkage of gut microbiome with cognition in hepatic encephalopathy Am J Physiol Gastrointest Liver Physiol 302 2012 G168 G175
44. H. Lu, Z. Wu, W. Xu, J. Yang, Y. Chen, and L. Li Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients Microb Ecol 61 2011 693 703
45. M. Xu, B. Wang, Y. Fu, Y. Chen, F. Yang, and H. Lu Changes of fecal Bifidobacterial species in adult patients with hepatitis B-Virus-induced chronic liver diseases Microb Ecol 63 2012 304 313
46. F. Bäckhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, and J.I. Gordon Host-bacterial mutualism in the human intestine Science 307 2005 1915 1920
47. R.E. Ley, F. Bäckhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon Obesity alters gut microbial ecology PNAS 102 2005 11070 11075
48. A. Schwiertz, D. Taras, K. Schafer, S. Beijer, N.A. Bos, and C. Donus Microbiota and SCFA in lean and overweight healthy subject Obesity 18 2010 190 195
49. F. Bäckhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, and A. Nagy The gut microbiota as an environmental factor that regulates fat storage PNAS 101 2004 15718 15723
50. M.E. Dumas, R.H. Barton, A. Toye, O. Cloarec, C. Blancher, and A. Rothwell Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice PNAS 103 2006 12511 12516
51. Z. Wang, E. Klipfell, B.J. Bennett, R. Koeth, B.S. Levison, and B. Dugar Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 472 2011 57 63
52. K. Rak, and D.J. Rader Cardiovascular disease: the diet-microbe morbid union Nature 472 2011 40 41
53. J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, and T. Strowig Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
54. C.S. Schaffert, M.J. Duryee, C.D. Hunter, B.C. Hamilton 3rd, A.L. DeVeney, and M.M. Huerter Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease World J Gastroenterol 15 2009 1209 1218
55. J. Almeida, S. Galhenage, J. Yu, J. Kurtovic, and S.M. Riordan Gut flora and bacterial translocation in chronic liver disease World J Gastroenterol 12 2006 1493 1502
56. M.J. Cohen, T. Sahar, S. Benenson, E. Elinav, M. Brezis, and K. Soares-Weiser Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding Cochrane Database Syst Rev 2 2009 CD004791
57. N.C. Chavez-Tapia, T. Barrientos-Gutierrez, F.I. Tellez-Avila, K. Soares-Weiser, and M. Uribe Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding Cochrane Database Syst Rev 9 2010 CD002907
58. B. Rasaratnam, N. Connelly, and J. Chin-Dusting Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination? Clin Sci 107 2004 425 434
59. N.M. Bass, K.D. Mullen, A. Sanyal, F. Poordad, G. Neff, and C.B. Leevy Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071 1081
60. S.S. Sidhu, O. Goyal, B.P. Mishra, A. Sood, R.S. Chhina, and R.K. Soni Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial) Am J Gastroenterol 106 2011 307 316
61. B.A. Carter, and S.J. Karpen Intestinal failure-associated liver disease: management and treatment strategies past, present, and future Semin Liver Dis 27 2007 251 258
62. A.R. Barclay, L.M. Beattie, L.T. Weaver, and D.C. Wilson Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children Aliment Pharmacol Ther 33 2011 175 184
63. Z. Li, S. Yang, H. Lin, J. Huang, P.A. Watkins, and A.B. Moser Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343 350
64. X. Ma, J. Hua, and Z. Li Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells J Hepatol 49 2008 821 830
65. A. Velayudham, A. Dolganiuc, M. Ellis, J. Petrasek, K. Kodys, and P. Mandrekar VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice Hepatology 49 2009 989 997
66. R.Y. Xu, Y.P. Wan, Q.Y. Fang, W. Lu, and W. Cai Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model J Clin Biochem Nutr 50 2012 72 77
67. R. Wall, R.P. Ross, F. Shanahan, L. O'Mahony, C. O'Mahony, and M. Coakley Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues Am J Clin Nutr 89 2009 1393 1401
68. R. Wall, T.M. Marques, O. O'Sullivan, R.P. Ross, F. Shanahan, and E.M. Quigley Contrasting effects of Bifidobacterium breve DPC 6330 and Bifidobacterium breve NCIMB 702258 on fatty acid metabolism and gut microbiota composition Am J Clin Nutr 95 2012 1278 1287
69. K. Nagao, N. Inoue, Y.M. Wang, B. Shirouchi, and T. Yanagita Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats J Nutr 135 2005 9 13
70. J.B. Ewaschuk, J.W. Walter, H. Diaz, and K.L. Madsen Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice J Nutr 136 2006 1483 1487
71. P.D. Cani, S. Possemiers, T. Van den Wiele, Y. Guiot, A. Everard, and O. Rottier Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability Gut 58 2009 1091 1103
72. J.A. Parnell, M. Raman, K.P. Rioux, and R.A. Reimer The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance Liver Int 32 2012 701 711
73. C.B. Forsyth, A. Farhadi, S.M. Jakate, Y. Tang, M. Shaikh, and A. Keshavarzian Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis Alcohol 43 2009 163 172
74. Y. Wang, Y. Liu, A. Sidhu, Z. Ma, C. McClain, and W. Feng Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury Am J Physiol Gastrointest Liver Physiol 303 2012 G32 G41
75. Y. Wang, I. Kirpich, Y. Liu, Z. Ma, S. Barve, and C.J. McClain Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury Am J Pathol 179 2011 2866 2875
76. R. Wiest, F. Chen, G. Cadelina, R.J. Groszmann, and G. Garcia-Tsao Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension Dig Dis Sci 48 2003 1136 1141
77. D. Adawi, F.B. Kasravi, G. Molin, and B. Jeppsson Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat Hepatology 25 1997 642 647
78. L. Jia, and M.H. Zhang Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats World J Gastroenterol 11 2005 908 911
79. P. Rishi, S. Bharrhan, G. Singh, and I.P. Kaur Effect of Lactobacillus plantarum and l-arginine against endotoxin-induced liver injury in a rat model Life Sci 89 2011 847 853
80. S. Sharma, J. Chaturvedi, B.P. Chaudhari, R.L. Singh, and P. Kakkar Probiotic Enterococcus lactis IITRHR1 protects against acetaminophen-induced hepatotoxicity Nutrition 28 2012 173 181
81. Y.T. Li, L. Wang, Y. Chen, Y.B. Chen, H.Y. Wang, and Z.W. Wu Effects of gut microflora on hepatic damage after acute liver injury in rats J Trauma 68 2010 76 83
82. J. Ewaschuk, R. Endersby, D. Thiel, H. Diaz, J. Backer, and M. Ma Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis Hepatology 46 2007 841 850
83. N. Osman, D. Adawi, S. Ahrne, B. Jeppsson, and G. Molin Endotoxin- and d-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry Dig Liver Dis 39 2007 849 856
84. J. Wu, X. Wang, W. Cai, L. Hong, and Q. Tang Bifidobacterium adolescentis supplementation ameliorates parenteral nutrition-induced liver injury in infant rabbits Dig Dis Sci 55 2010 2814 2820
85. J. Lata, J. Jurankova, M. Kopacova, and P. Vitek Probiotics in hepatology World J Gastroenterol 17 2011 2890 2896
86. S.W. Gratz, H. Mykkanen, and H.S. El-Nezami Probiotics and gut health: a special focus on liver diseases World J Gastroenterol 16 2010 403 410
87. H.Y. Zhao, H.J. Wang, Z. Lu, and S.Z. Xu Intestinal microflora in patients with liver cirrhosis Chin J Dig Dis 5 2004 64 67
88. F. Lirussi, E. Mastropasqua, S. Orando, and R. Orlando Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis Cochrane Database Syst Rev 1 2007 CD005165
89. R. Aller, D.A. De Luis, O. Izaola, R. Conde, M. Gonzalez Sagrado, and D. Primo Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial Eur Rev Med Pharmacol Sci 15 2011 1090 1095
90. P. Vajro, C. Mandato, M.R. Licenziati, A. Franzese, D.F. Vitale, and S. Lenta Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease J Pediatr Gastroenterol Nutr 52 2011 740 743
91. I.A. Kirpich, N.V. Solovieva, S.N. Leikhter, N.A. Shidakova, O.V. Lebedeva, and P.I. Sidorov Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study Alcohol 42 2008 675 682
92. Q. Liu, Z.P. Duan, D.K. Ha, S. Bengmark, J. Kurtovic, and S.M. Riordan Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 39 2004 1441 1449
93. M. Malaguarnera, F. Greco, G. Barone, M.P. Gargante, G. Malaguarnera, and M.A. Toscano Bifidobacterium longum with fructo-oligosaccheride (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study Dig Dis Sci 52 2007 3259 3265
94. M. Malaguarnera, M.P. Gargante, G. Malaguarnera, M. Salmeri, S. Mastrojeni, and L. Rampello Bifidobacterium combined with fructo-oligosaccheride versus lactulose in the treatment of patients with hepatic encephalopathy Eur J Gastroenterol Hepatol 22 2010 199 206
95. V.V. Mittal, B.C. Sharma, P. Sharma, and S.K. Sarin A randomized controlled trial comparing lactulose, probiotics and l-ornithine l-aspartate in treatment of minimal hepatic encephalopathy Eur J Gastroenterol Hepatol 23 2011 725 732
96. R.G. McGee, A. Bakens, K. Wiley, S.M. Riordan, and A.C. Webster Probiotics for patients with encephalopthay Cochrane Database Syst Rev 11 2011 CD008716
97. S. Shukla, A. Shukla, S. Mehboob, and S. Guha Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy Aliment Pharmacol Ther 33 2011 662 671
98. J. Lata, I. Novotny, V. Pribramska, J. Jurankova, P. Fric, and R. Kroupa The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study Eur J Gastroenterol Hepatol 19 2007 1111 1113
99. V. Stadlbauer, R.P. Mookerjee, S. Hodges, G.A. Wright, N.A. Davies, and R. Jalan Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated cirrhosis J Hepatol 48 2008 945 951
100. C. Loguerico, A. Federico, C. Tuccillo, F. Terracciano, M.V. D'Auria, and C. De Simone Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases J Clin Gastroenterol 39 2005 540 543
101. K.M. Eltawil, M. Laryea, K. Peltekian, and M. Molinari Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis World J Gastroenterol 18 2012 767 777
102. P. Tandon, K. Moncrief, K. Madsen, M.C. Arrieta, R.J. Owen, and V.G. Bain Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study Liver Int 29 2009 1110 1115
103. D. Pereg, A. Kotliroff, N. Gadoth, R. Hadary, M. Lishner, and Y. Kitay-Cohen Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study Nutrition 27 2011 177 181
104. F.P. Vleggaar, J.F. Monkelbaan, and K.J. van Erpecum Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study Eur J Gastroenterol Hepatol 20 2008 688 692
105. H.S. El-Nezami, N.N. Polychronaki, J. Ma, H. Zhu, W. Ling, and E.K. Salminen Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China Am J Clin Nutr 83 2006 1199 1203
106. J.K. Nicholson, E. Holmes, J. Kinross, R. Burcelin, G. Gibson, and W. Jia Host-gut microbiota metabolic interactions Science 336 2012 1262 1267
107. E. Seki, and B. Schnabl Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut J Physiol 590 Pt 3 2012 447 458
108. C. Cesaro, A. Tiso, A. Del Prete, R. Cariello, C. Tuccillo, and G. Cotticelli Gut microbiota and probiotics in chronic liver diseases Dig Liver Dis 43 2011 431 438
109. C. Blanco, C. Loguercio, M.V. Machado, and H. Cortez-Pinto Gut microbiota and nonalcoholic fatty liver disease Ann Hepatol 11 2012 440 449
110. D. Compare, P. Coccoli, A. Rocco, O.M. Nardone, S. De Maria, and M. Cartenì Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 22 2012 471 476
111. T.H. Frazier, J.K. DiBaise, and C.J. McClain Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury J Parenter Enteral Nutr 35 2011 14S 20S